“…In the last decade, over 50 entries of the POT family were deposited in the Protein Data Bank (PDB), representing eleven bacterial and two mammalian homologs, bound to eight unique natural di-and tripeptides (Ala-Phe, Ala-Glu, Ala-Gln, Ala-Leu, Phe-Ala, Phe-Ala-Gln, Ala-Ala-Ala, alafosfalin), peptidomimetic drugs (valaciclovir, valganciclovir, 5-aminolevulinic acid) and a potent transport inhibitor Lys[Z(NO2)]-Val [3][4][5][6][7][8]10,18,[31][32][33][34][35][36][37][38][39][40][41] . These efforts revealed the basic principle underlying peptide binding in POTs which can be described as an electrostatic clamping mechanism between the invariable part of peptides (N-and C-termini as well as the peptide backbone) and conserved residues in the transporter (mainly via arginine, lysine, glutamate, asparagine and tyrosine residues).…”